T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTOR
801
DELISTED
MERITOR, Inc.
MTOR
| $88.9M | 0.01% |
3,587,859
-143,041
| -4% | -$3.65M |
|
|
OZON
802
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $88.9M | 0.01% |
3,000,742
-31,255
| -1% | -$1.29M |
|
803
SPS Commerce
SPSC
$2.86B
| $88.8M | 0.01% |
624,077
-53,477
| -8% | -$8.01M |
|
804
Apollo Global Management
APO
$84.8B
| $88.7M | 0.01% |
1,224,667
-1,881,191
| -61% | -$136M |
|
805
Encore Capital Group
ECPG
$2.15B
| $88.4M | 0.01% |
1,423,174
-888,299
| -38% | -$50M |
|
806
Kilroy Realty
KRC
$4.3B
| $88.1M | 0.01% |
1,326,091
-277,367
| -17% | -$18.9M |
|
807
Johnson Controls International
JCI
$91.7B
| $88M | 0.01% |
1,082,553
-49,881
| -4% | -$3.77M |
|
808
Snap-on
SNA
$20.9B
| $87.9M | 0.01% |
408,166
-561,131
| -58% | -$120M |
|
|
SKX
809
DELISTED
Skechers
SKX
| $87.6M | 0.01% |
2,017,314
-67,617
| -3% | -$3.03M |
|
|
INFO
810
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $87.5M | 0.01% |
658,037
-17,218
| -3% | -$2.19M |
|
811
Teradyne
TER
$64.2B
| $86.9M | 0.01% |
531,405
-43,665
| -8% | -$6.14M |
|
812
Zai Lab
ZLAB
$2.92B
| $86.4M | 0.01% |
1,374,964
+8,197
| +0.6% | +$695K |
|
|
NXDR
813
Nextdoor Holdings
NXDR
$998M
| $85.8M | 0.01% |
10,874,248
+5,889,083
| +118% | +$60.8M |
|
814
Steel Dynamics
STLD
$37.3B
| $85.7M | 0.01% |
1,380,819
+52,122
| +4% | +$3.26M |
|
|
FORG
815
DELISTED
ForgeRock, Inc.
FORG
| $85.1M | 0.01% |
3,187,262
+877,076
| +38% | +$25.3M |
|
816
Brunswick
BC
$5.29B
| $84.7M | 0.01% |
841,233
-11,216
| -1% | -$1.1M |
|
817
Monte Rosa Therapeutics
GLUE
$1.35B
| $84.7M | 0.01% |
4,146,919
+999,985
| +32% | +$20.9M |
|
818
Essential Properties Realty Trust
EPRT
$6.71B
| $84.6M | 0.01% |
2,935,647
+41,156
| +1% | +$1.18M |
|
819
CarMax
KMX
$8.52B
| $84.6M | 0.01% |
649,480
-46,240
| -7% | -$6.47M |
|
|
ISEE
820
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $84.4M | 0.01% |
5,046,287
+66,889
| +1% | +$1.1M |
|
821
PTC Therapeutics
PTCT
$6.01B
| $83.9M | 0.01% |
2,106,561
+1,501
| +0.1% | +$57.5K |
|
822
Orion
OEC
$360M
| $83.9M | 0.01% |
4,568,931
-346,183
| -7% | -$6.45M |
|
|
ANSS
823
DELISTED
Ansys
ANSS
| $83.3M | 0.01% |
207,772
-6,961
| -3% | -$2.67M |
|
824
Parsons
PSN
$5.08B
| $83.2M | 0.01% |
2,471,313
-25,934
| -1% | -$900K |
|
825
Tidewater
TDW
$4.55B
| $83.1M | 0.01% |
7,755,400
+11,555
| +0.1% | +$136K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.